Combined xCT and mTOR Inhibition as a New Therapeutic Option for Pancreatic Adenocarcinoma. (2022) - Newcomer, K.; Spitzer, D.; Ross, L.; Caldwell, K.; Vangveravong, S.; Van Tine, B.; Hawkins, W.